Bldg. 433- north refurbishment & bldg. 433- infrastructure
Ended Awarded Last action
- Contract number
- HHSN26100022
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,527,878
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $4,527,878.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost No Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $23,591 | |
| Funding Only Action | $47,770 | |
| Other Administrative Action | $48,946 | |
| Other Administrative Action | $149,966 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $9,545 | |
| Change Order | $60,545 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $1,114,362 | |
| Original award | $3,073,153 |
Show all 11
About this award
The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on August 15, 2016, with a ceiling value of $4,527,878.03 for Building 433 North refurbishment and infrastructure work, with final funding modification (MOD 010) completing the order on September 6, 2019.
Place of performance is Frederick, Maryland. The delivery order is priced on a cost-no-fee basis. Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., operates as a Federally Funded Research and Development Center (FFRDC) contractor for NCI and provides biomedical research and facilities support services.
Quick answers
Who was awarded contract HHSN26100022?
HHSN26100022 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on August 15, 2016.
How much is contract HHSN26100022 worth?
The government has obligated $4,527,878 on HHSN26100022.
Is contract HHSN26100022 an order under another contract?
Yes. HHSN26100022 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract HHSN26100022 competed?
The extent of competition for HHSN26100022 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award